

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.10267672 |
| 2 | ribosome assembly (GO:0042255) | 5.07838425 |
| 3 | ATP synthesis coupled proton transport (GO:0015986) | 4.65525183 |
| 4 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.65525183 |
| 5 | chaperone-mediated protein transport (GO:0072321) | 4.59271271 |
| 6 | proteasome assembly (GO:0043248) | 4.40597204 |
| 7 | establishment of integrated proviral latency (GO:0075713) | 4.33198694 |
| 8 | mitotic metaphase plate congression (GO:0007080) | 4.08896677 |
| 9 | L-phenylalanine metabolic process (GO:0006558) | 4.03465131 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.03465131 |
| 11 | respiratory electron transport chain (GO:0022904) | 4.00902443 |
| 12 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.98161101 |
| 13 | pseudouridine synthesis (GO:0001522) | 3.94087446 |
| 14 | electron transport chain (GO:0022900) | 3.90306531 |
| 15 | ribosome biogenesis (GO:0042254) | 3.84510580 |
| 16 | DNA deamination (GO:0045006) | 3.84282296 |
| 17 | glycine metabolic process (GO:0006544) | 3.83706203 |
| 18 | aldehyde catabolic process (GO:0046185) | 3.82334643 |
| 19 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.82149288 |
| 20 | L-phenylalanine catabolic process (GO:0006559) | 3.82149288 |
| 21 | cullin deneddylation (GO:0010388) | 3.78820777 |
| 22 | * protein targeting to mitochondrion (GO:0006626) | 3.74028324 |
| 23 | oxidative phosphorylation (GO:0006119) | 3.73595828 |
| 24 | serine family amino acid biosynthetic process (GO:0009070) | 3.71075705 |
| 25 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.69420482 |
| 26 | establishment of viral latency (GO:0019043) | 3.66902355 |
| 27 | rRNA processing (GO:0006364) | 3.64732881 |
| 28 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.60639353 |
| 29 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.60191356 |
| 30 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.59659014 |
| 31 | protein deneddylation (GO:0000338) | 3.58769513 |
| 32 | regulation of ligase activity (GO:0051340) | 3.58438355 |
| 33 | maturation of 5.8S rRNA (GO:0000460) | 3.58033268 |
| 34 | glyoxylate metabolic process (GO:0046487) | 3.56762450 |
| 35 | purine nucleobase biosynthetic process (GO:0009113) | 3.56568881 |
| 36 | spliceosomal snRNP assembly (GO:0000387) | 3.54895026 |
| 37 | DNA strand elongation (GO:0022616) | 3.51966595 |
| 38 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.51960448 |
| 39 | L-methionine salvage (GO:0071267) | 3.47080545 |
| 40 | L-methionine biosynthetic process (GO:0071265) | 3.47080545 |
| 41 | amino acid salvage (GO:0043102) | 3.47080545 |
| 42 | rRNA metabolic process (GO:0016072) | 3.46655928 |
| 43 | * protein localization to mitochondrion (GO:0070585) | 3.44221914 |
| 44 | aromatic amino acid family catabolic process (GO:0009074) | 3.44166691 |
| 45 | cysteine metabolic process (GO:0006534) | 3.42738512 |
| 46 | serine family amino acid metabolic process (GO:0009069) | 3.42190448 |
| 47 | nucleobase biosynthetic process (GO:0046112) | 3.41828863 |
| 48 | serine family amino acid catabolic process (GO:0009071) | 3.39680897 |
| 49 | * establishment of protein localization to mitochondrion (GO:0072655) | 3.37508554 |
| 50 | metaphase plate congression (GO:0051310) | 3.36207493 |
| 51 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.33932901 |
| 52 | transcription from mitochondrial promoter (GO:0006390) | 3.33517541 |
| 53 | L-serine metabolic process (GO:0006563) | 3.31566921 |
| 54 | regulation of translational termination (GO:0006449) | 3.31400493 |
| 55 | rRNA methylation (GO:0031167) | 3.29169526 |
| 56 | mitochondrial RNA metabolic process (GO:0000959) | 3.25423875 |
| 57 | IMP biosynthetic process (GO:0006188) | 3.25004612 |
| 58 | 7-methylguanosine mRNA capping (GO:0006370) | 3.24817325 |
| 59 | DNA replication checkpoint (GO:0000076) | 3.24246920 |
| 60 | negative regulation of protein ubiquitination (GO:0031397) | 3.23925163 |
| 61 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.23497835 |
| 62 | CENP-A containing nucleosome assembly (GO:0034080) | 3.22925316 |
| 63 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.22445515 |
| 64 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.20849139 |
| 65 | cell cycle G1/S phase transition (GO:0044843) | 3.20849139 |
| 66 | branched-chain amino acid catabolic process (GO:0009083) | 3.20540580 |
| 67 | lysine metabolic process (GO:0006553) | 3.20434977 |
| 68 | lysine catabolic process (GO:0006554) | 3.20434977 |
| 69 | protein maturation by protein folding (GO:0022417) | 3.20207776 |
| 70 | regulation of mitochondrial translation (GO:0070129) | 3.20078349 |
| 71 | tricarboxylic acid cycle (GO:0006099) | 3.17769074 |
| 72 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.17240186 |
| 73 | folic acid metabolic process (GO:0046655) | 3.17030750 |
| 74 | negative regulation of ligase activity (GO:0051352) | 3.16839784 |
| 75 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.16839784 |
| 76 | ribosomal small subunit assembly (GO:0000028) | 3.16672381 |
| 77 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.16610570 |
| 78 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.15946234 |
| 79 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.15709402 |
| 80 | 7-methylguanosine RNA capping (GO:0009452) | 3.14564547 |
| 81 | RNA capping (GO:0036260) | 3.14564547 |
| 82 | formation of translation preinitiation complex (GO:0001731) | 3.14126775 |
| 83 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.13591245 |
| 84 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.13591245 |
| 85 | NADH dehydrogenase complex assembly (GO:0010257) | 3.13591245 |
| 86 | indole-containing compound catabolic process (GO:0042436) | 3.11853105 |
| 87 | indolalkylamine catabolic process (GO:0046218) | 3.11853105 |
| 88 | tryptophan catabolic process (GO:0006569) | 3.11853105 |
| 89 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.10761186 |
| 90 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.10761186 |
| 91 | viral mRNA export from host cell nucleus (GO:0046784) | 3.10103361 |
| 92 | telomere maintenance via recombination (GO:0000722) | 3.09459667 |
| 93 | NADH metabolic process (GO:0006734) | 3.09399300 |
| 94 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.08916878 |
| 95 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.08916878 |
| 96 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.08916878 |
| 97 | rRNA modification (GO:0000154) | 3.08373540 |
| 98 | protein localization to kinetochore (GO:0034501) | 3.08245515 |
| 99 | ribosomal small subunit biogenesis (GO:0042274) | 3.08194986 |
| 100 | transcription from RNA polymerase I promoter (GO:0006360) | 3.07963132 |
| 101 | chromatin remodeling at centromere (GO:0031055) | 3.07948377 |
| 102 | positive regulation of cell cycle arrest (GO:0071158) | 3.06097598 |
| 103 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 3.05343840 |
| 104 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.04880775 |
| 105 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.03494839 |
| 106 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.03440721 |
| 107 | ribosomal large subunit biogenesis (GO:0042273) | 3.02462061 |
| 108 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.02330207 |
| 109 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.02330207 |
| 110 | tryptophan metabolic process (GO:0006568) | 3.01988177 |
| 111 | kynurenine metabolic process (GO:0070189) | 3.01897853 |
| 112 | DNA damage response, detection of DNA damage (GO:0042769) | 3.01133734 |
| 113 | termination of RNA polymerase I transcription (GO:0006363) | 3.00971912 |
| 114 | protein localization to chromosome, centromeric region (GO:0071459) | 2.99779464 |
| 115 | termination of RNA polymerase III transcription (GO:0006386) | 2.98954213 |
| 116 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.98954213 |
| 117 | cellular ketone body metabolic process (GO:0046950) | 2.98004075 |
| 118 | tRNA methylation (GO:0030488) | 2.97772766 |
| 119 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.97763766 |
| 120 | sulfur amino acid biosynthetic process (GO:0000097) | 2.97538052 |
| 121 | metallo-sulfur cluster assembly (GO:0031163) | 2.96794939 |
| 122 | iron-sulfur cluster assembly (GO:0016226) | 2.96794939 |
| 123 | mitotic sister chromatid segregation (GO:0000070) | 2.96637431 |
| 124 | histone mRNA metabolic process (GO:0008334) | 2.96479893 |
| 125 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.94619325 |
| 126 | viral transcription (GO:0019083) | 2.94399458 |
| 127 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.94267539 |
| 128 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.93795355 |
| 129 | translation (GO:0006412) | 2.91039201 |
| 130 | maturation of SSU-rRNA (GO:0030490) | 2.89545026 |
| 131 | ubiquinone biosynthetic process (GO:0006744) | 2.87901833 |
| 132 | quinone biosynthetic process (GO:1901663) | 2.87901833 |
| 133 | aromatic amino acid family metabolic process (GO:0009072) | 2.87522364 |
| 134 | sulfur amino acid catabolic process (GO:0000098) | 2.86416291 |
| 135 | translational termination (GO:0006415) | 2.85281410 |
| 136 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.84543531 |
| 137 | positive regulation of ligase activity (GO:0051351) | 2.84309840 |
| 138 | protein complex biogenesis (GO:0070271) | 2.84059432 |
| 139 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.83830391 |
| 140 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.80399884 |
| 141 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.80289364 |
| 142 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.79656498 |
| 143 | bile acid biosynthetic process (GO:0006699) | 2.79317247 |
| 144 | methionine metabolic process (GO:0006555) | 2.78515788 |
| 145 | amino-acid betaine metabolic process (GO:0006577) | 2.76640238 |
| 146 | cellular component biogenesis (GO:0044085) | 2.74680216 |
| 147 | alpha-amino acid catabolic process (GO:1901606) | 2.73895486 |
| 148 | regulation of cellular amine metabolic process (GO:0033238) | 2.71976166 |
| 149 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.71805361 |
| 150 | branched-chain amino acid metabolic process (GO:0009081) | 2.71659526 |
| 151 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.69777588 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.41980063 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.12762416 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.99948793 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.70693039 |
| 5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.69378264 |
| 6 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.59780153 |
| 7 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.53579529 |
| 8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.42353285 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.35412370 |
| 10 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.35370888 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.28761207 |
| 12 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.16451627 |
| 13 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.89986294 |
| 14 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.88828668 |
| 15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.84855592 |
| 16 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.60714356 |
| 17 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.54017172 |
| 18 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.52592334 |
| 19 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.51106269 |
| 20 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.50723820 |
| 21 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.42742235 |
| 22 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.37432533 |
| 23 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.36317726 |
| 24 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.35988299 |
| 25 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.30627694 |
| 26 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.30482055 |
| 27 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.23012649 |
| 28 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.21446345 |
| 29 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.19381696 |
| 30 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.14883008 |
| 31 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.10384356 |
| 32 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.07545273 |
| 33 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.02361236 |
| 34 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.93119400 |
| 35 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.91541737 |
| 36 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.91249461 |
| 37 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.88372393 |
| 38 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.87915406 |
| 39 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.86772611 |
| 40 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.77446007 |
| 41 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.75316458 |
| 42 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.74996049 |
| 43 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.71790324 |
| 44 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.70398551 |
| 45 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.67101946 |
| 46 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.63824574 |
| 47 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.58880554 |
| 48 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.57193351 |
| 49 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.55037137 |
| 50 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.53074897 |
| 51 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.51778836 |
| 52 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.50496856 |
| 53 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.49761779 |
| 54 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.48375004 |
| 55 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.46770122 |
| 56 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.41088769 |
| 57 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.40550293 |
| 58 | * NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.38117571 |
| 59 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.36867344 |
| 60 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.34269164 |
| 61 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.33325870 |
| 62 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.30571886 |
| 63 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.28202689 |
| 64 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.28032554 |
| 65 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.25204362 |
| 66 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.24677967 |
| 67 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.24268798 |
| 68 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.20014802 |
| 69 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.19165264 |
| 70 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18410651 |
| 71 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.16792085 |
| 72 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.15296465 |
| 73 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.14196105 |
| 74 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.13207711 |
| 75 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.12869930 |
| 76 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.12680580 |
| 77 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.12088151 |
| 78 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11796414 |
| 79 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.06959425 |
| 80 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.06394907 |
| 81 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.05444410 |
| 82 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.01618865 |
| 83 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.01325648 |
| 84 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.00413606 |
| 85 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.99572942 |
| 86 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.97017158 |
| 87 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.96250419 |
| 88 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.95650365 |
| 89 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.94868634 |
| 90 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.94551502 |
| 91 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.93855259 |
| 92 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.93479033 |
| 93 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.92908810 |
| 94 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.92359550 |
| 95 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.91837605 |
| 96 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.91279380 |
| 97 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.89137890 |
| 98 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.88906915 |
| 99 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.87745514 |
| 100 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.87067643 |
| 101 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.84050681 |
| 102 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83205552 |
| 103 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.80832861 |
| 104 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.80761405 |
| 105 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.78790211 |
| 106 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.78450337 |
| 107 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.78445754 |
| 108 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.78337549 |
| 109 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.78180454 |
| 110 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 0.77187013 |
| 111 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.76522576 |
| 112 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.76212711 |
| 113 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.75940026 |
| 114 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.75834206 |
| 115 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.73218251 |
| 116 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.72433777 |
| 117 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.71799621 |
| 118 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.70541046 |
| 119 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.68717342 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 5.86128019 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.54753137 |
| 3 | MP0005360_urolithiasis | 4.73936676 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.22911587 |
| 5 | MP0005365_abnormal_bile_salt | 3.87483939 |
| 6 | MP0003950_abnormal_plasma_membrane | 3.59712232 |
| 7 | MP0003693_abnormal_embryo_hatching | 3.32531274 |
| 8 | MP0003186_abnormal_redox_activity | 3.21450295 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 3.15389755 |
| 10 | MP0006036_abnormal_mitochondrial_physio | 2.93175210 |
| 11 | MP0004957_abnormal_blastocyst_morpholog | 2.77936471 |
| 12 | MP0005332_abnormal_amino_acid | 2.66648000 |
| 13 | MP0003195_calcinosis | 2.56967361 |
| 14 | MP0009379_abnormal_foot_pigmentation | 2.50328511 |
| 15 | MP0001764_abnormal_homeostasis | 2.29232432 |
| 16 | MP0009697_abnormal_copulation | 2.26033862 |
| 17 | MP0003646_muscle_fatigue | 2.25050220 |
| 18 | MP0005083_abnormal_biliary_tract | 2.18023583 |
| 19 | MP0010329_abnormal_lipoprotein_level | 2.09167133 |
| 20 | MP0003718_maternal_effect | 1.97249678 |
| 21 | MP0006035_abnormal_mitochondrial_morpho | 1.96550770 |
| 22 | MP0009840_abnormal_foam_cell | 1.94732549 |
| 23 | MP0003941_abnormal_skin_development | 1.84105523 |
| 24 | MP0005319_abnormal_enzyme/_coenzyme | 1.75435573 |
| 25 | MP0004019_abnormal_vitamin_homeostasis | 1.65963205 |
| 26 | MP0004233_abnormal_muscle_weight | 1.65838476 |
| 27 | MP0003252_abnormal_bile_duct | 1.63254505 |
| 28 | MP0002837_dystrophic_cardiac_calcinosis | 1.63010099 |
| 29 | MP0010094_abnormal_chromosome_stability | 1.61719344 |
| 30 | MP0005266_abnormal_metabolism | 1.56900360 |
| 31 | MP0005451_abnormal_body_composition | 1.55804147 |
| 32 | MP0000609_abnormal_liver_physiology | 1.55466008 |
| 33 | MP0003111_abnormal_nucleus_morphology | 1.53292843 |
| 34 | MP0008932_abnormal_embryonic_tissue | 1.49235125 |
| 35 | MP0001666_abnormal_nutrient_absorption | 1.47883380 |
| 36 | MP0003221_abnormal_cardiomyocyte_apopto | 1.44867892 |
| 37 | MP0000313_abnormal_cell_death | 1.44838217 |
| 38 | MP0003077_abnormal_cell_cycle | 1.42538162 |
| 39 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.41789643 |
| 40 | MP0008007_abnormal_cellular_replicative | 1.40654197 |
| 41 | MP0005670_abnormal_white_adipose | 1.39340256 |
| 42 | MP0008058_abnormal_DNA_repair | 1.37681776 |
| 43 | MP0009643_abnormal_urine_homeostasis | 1.35408209 |
| 44 | MP0005376_homeostasis/metabolism_phenot | 1.29541017 |
| 45 | MP0002118_abnormal_lipid_homeostasis | 1.27411440 |
| 46 | MP0002877_abnormal_melanocyte_morpholog | 1.25848357 |
| 47 | MP0005330_cardiomyopathy | 1.25522707 |
| 48 | MP0000372_irregular_coat_pigmentation | 1.25509856 |
| 49 | MP0005636_abnormal_mineral_homeostasis | 1.23843616 |
| 50 | MP0005501_abnormal_skin_physiology | 1.23244501 |
| 51 | MP0003786_premature_aging | 1.19524016 |
| 52 | MP0002332_abnormal_exercise_endurance | 1.18138725 |
| 53 | MP0003011_delayed_dark_adaptation | 1.17998822 |
| 54 | MP0003191_abnormal_cellular_cholesterol | 1.17574867 |
| 55 | MP0002796_impaired_skin_barrier | 1.15498977 |
| 56 | MP0005408_hypopigmentation | 1.13503019 |
| 57 | MP0001881_abnormal_mammary_gland | 1.09846606 |
| 58 | MP0010234_abnormal_vibrissa_follicle | 1.08953663 |
| 59 | MP0002102_abnormal_ear_morphology | 1.08580487 |
| 60 | MP0000598_abnormal_liver_morphology | 1.08574911 |
| 61 | MP0002019_abnormal_tumor_incidence | 1.06000983 |
| 62 | MP0002160_abnormal_reproductive_system | 1.05221039 |
| 63 | MP0005084_abnormal_gallbladder_morpholo | 1.04142097 |
| 64 | MP0002210_abnormal_sex_determination | 1.04026811 |
| 65 | MP0004043_abnormal_pH_regulation | 1.03822446 |
| 66 | MP0008057_abnormal_DNA_replication | 1.02590201 |
| 67 | MP0004084_abnormal_cardiac_muscle | 1.02540923 |
| 68 | MP0010307_abnormal_tumor_latency | 1.01550746 |
| 69 | MP0001929_abnormal_gametogenesis | 0.99781296 |
| 70 | MP0002138_abnormal_hepatobiliary_system | 0.99623931 |
| 71 | MP0001756_abnormal_urination | 0.99486117 |
| 72 | MP0003656_abnormal_erythrocyte_physiolo | 0.99052513 |
| 73 | MP0001661_extended_life_span | 0.97214105 |
| 74 | MP0001730_embryonic_growth_arrest | 0.96887431 |
| 75 | MP0000358_abnormal_cell_content/ | 0.95965622 |
| 76 | MP0001853_heart_inflammation | 0.94173776 |
| 77 | MP0002396_abnormal_hematopoietic_system | 0.94077117 |
| 78 | MP0002876_abnormal_thyroid_physiology | 0.93834119 |
| 79 | MP0008260_abnormal_autophagy | 0.92965430 |
| 80 | MP0002132_abnormal_respiratory_system | 0.92540458 |
| 81 | MP0000749_muscle_degeneration | 0.89667086 |
| 82 | MP0000750_abnormal_muscle_regeneration | 0.88222626 |
| 83 | MP0001542_abnormal_bone_strength | 0.87199771 |
| 84 | MP0002085_abnormal_embryonic_tissue | 0.84685070 |
| 85 | MP0002086_abnormal_extraembryonic_tissu | 0.84210248 |
| 86 | MP0002269_muscular_atrophy | 0.83958115 |
| 87 | MP0008469_abnormal_protein_level | 0.81098546 |
| 88 | MP0005395_other_phenotype | 0.80520470 |
| 89 | MP0008995_early_reproductive_senescence | 0.79686498 |
| 90 | MP0002163_abnormal_gland_morphology | 0.78463576 |
| 91 | MP0009763_increased_sensitivity_to | 0.77811711 |
| 92 | MP0005666_abnormal_adipose_tissue | 0.77702682 |
| 93 | MP0004215_abnormal_myocardial_fiber | 0.77189007 |
| 94 | MP0005389_reproductive_system_phenotype | 0.76983775 |
| 95 | MP0002084_abnormal_developmental_patter | 0.76276836 |
| 96 | MP0001216_abnormal_epidermal_layer | 0.75492641 |
| 97 | MP0008789_abnormal_olfactory_epithelium | 0.75424377 |
| 98 | MP0000627_abnormal_mammary_gland | 0.73835045 |
| 99 | MP0000653_abnormal_sex_gland | 0.73571057 |
| 100 | MP0009053_abnormal_anal_canal | 0.72874873 |
| 101 | MP0009672_abnormal_birth_weight | 0.72806107 |
| 102 | MP0005384_cellular_phenotype | 0.71829958 |
| 103 | MP0001145_abnormal_male_reproductive | 0.71576080 |
| 104 | MP0003315_abnormal_perineum_morphology | 0.70650423 |
| 105 | MP0004036_abnormal_muscle_relaxation | 0.70055217 |
| 106 | MP0001727_abnormal_embryo_implantation | 0.69073753 |
| 107 | MP0002060_abnormal_skin_morphology | 0.69068535 |
| 108 | MP0003724_increased_susceptibility_to | 0.68251344 |
| 109 | MP0001919_abnormal_reproductive_system | 0.67207873 |
| 110 | MP0009642_abnormal_blood_homeostasis | 0.67014464 |
| 111 | MP0003868_abnormal_feces_composition | 0.67011650 |
| 112 | MP0005410_abnormal_fertilization | 0.66918282 |
| 113 | MP0002971_abnormal_brown_adipose | 0.66232976 |
| 114 | MP0005165_increased_susceptibility_to | 0.66175968 |
| 115 | MP0003699_abnormal_female_reproductive | 0.65800892 |
| 116 | MP0000762_abnormal_tongue_morphology | 0.64840730 |
| 117 | MP0000490_abnormal_crypts_of | 0.63681301 |
| 118 | MP0009333_abnormal_splenocyte_physiolog | 0.63306971 |
| 119 | MP0003984_embryonic_growth_retardation | 0.63100526 |
| 120 | MP0001697_abnormal_embryo_size | 0.62178616 |
| 121 | MP0003567_abnormal_fetal_cardiomyocyte | 0.61856567 |
| 122 | MP0002088_abnormal_embryonic_growth/wei | 0.61846408 |
| 123 | MP0001873_stomach_inflammation | 0.61834268 |
| 124 | MP0003123_paternal_imprinting | 0.61214470 |
| 125 | MP0001672_abnormal_embryogenesis/_devel | 0.60715672 |
| 126 | MP0005380_embryogenesis_phenotype | 0.60715672 |
| 127 | MP0001544_abnormal_cardiovascular_syste | 0.60619967 |
| 128 | MP0005385_cardiovascular_system_phenoty | 0.60619967 |
| 129 | MP0002080_prenatal_lethality | 0.60098014 |
| 130 | MP0002078_abnormal_glucose_homeostasis | 0.59976300 |
| 131 | MP0010352_gastrointestinal_tract_polyps | 0.59846100 |
| 132 | MP0000747_muscle_weakness | 0.59156943 |
| 133 | MP0008873_increased_physiological_sensi | 0.58970803 |
| 134 | MP0004782_abnormal_surfactant_physiolog | 0.57969027 |
| 135 | MP0005535_abnormal_body_temperature | 0.57312761 |
| 136 | MP0000350_abnormal_cell_proliferation | 0.57200458 |
| 137 | MP0001119_abnormal_female_reproductive | 0.55694465 |
| 138 | MP0000343_altered_response_to | 0.54800772 |
| 139 | MP0004130_abnormal_muscle_cell | 0.53898684 |
| 140 | MP0002970_abnormal_white_adipose | 0.53588724 |
| 141 | MP0010030_abnormal_orbit_morphology | 0.53574113 |
| 142 | MP0010771_integument_phenotype | 0.52938740 |
| 143 | MP0002006_tumorigenesis | 0.52381113 |
| 144 | MP0005621_abnormal_cell_physiology | 0.51723618 |
| 145 | MP0001529_abnormal_vocalization | 0.51556117 |
| 146 | MP0004185_abnormal_adipocyte_glucose | 0.51466649 |
| 147 | MP0009765_abnormal_xenobiotic_induced | 0.50392727 |
| 148 | MP0002972_abnormal_cardiac_muscle | 0.50222995 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 4.67278435 |
| 2 | Hepatic necrosis (HP:0002605) | 4.53431719 |
| 3 | Acute encephalopathy (HP:0006846) | 4.52940468 |
| 4 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.40133184 |
| 5 | Cerebral edema (HP:0002181) | 4.30300158 |
| 6 | Increased serum pyruvate (HP:0003542) | 4.19144345 |
| 7 | Abnormality of glycolysis (HP:0004366) | 4.19144345 |
| 8 | Mitochondrial inheritance (HP:0001427) | 4.16174237 |
| 9 | Hepatocellular necrosis (HP:0001404) | 4.13881430 |
| 10 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.06381387 |
| 11 | Increased CSF lactate (HP:0002490) | 4.01559004 |
| 12 | Hypobetalipoproteinemia (HP:0003563) | 3.92027227 |
| 13 | Hyperglycinemia (HP:0002154) | 3.83074238 |
| 14 | Progressive macrocephaly (HP:0004481) | 3.78138681 |
| 15 | Hyperglycinuria (HP:0003108) | 3.67627484 |
| 16 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.55290550 |
| 17 | Lethargy (HP:0001254) | 3.50180401 |
| 18 | Hyperammonemia (HP:0001987) | 3.47305034 |
| 19 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.46545793 |
| 20 | Abnormality of glycine metabolism (HP:0010895) | 3.46545793 |
| 21 | Lipid accumulation in hepatocytes (HP:0006561) | 3.44564465 |
| 22 | Dicarboxylic aciduria (HP:0003215) | 3.41611278 |
| 23 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.41611278 |
| 24 | Increased serum lactate (HP:0002151) | 3.40443609 |
| 25 | Intrahepatic cholestasis (HP:0001406) | 3.37030702 |
| 26 | Lactic acidosis (HP:0003128) | 3.35982609 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.32510886 |
| 28 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.31753419 |
| 29 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.31753419 |
| 30 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.30350333 |
| 31 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.25987854 |
| 32 | Increased hepatocellular lipid droplets (HP:0006565) | 3.24601995 |
| 33 | Aplastic anemia (HP:0001915) | 3.22090625 |
| 34 | Degeneration of anterior horn cells (HP:0002398) | 3.11135024 |
| 35 | Abnormality of the anterior horn cell (HP:0006802) | 3.11135024 |
| 36 | 3-Methylglutaconic aciduria (HP:0003535) | 3.11092999 |
| 37 | Type I transferrin isoform profile (HP:0003642) | 3.11044362 |
| 38 | Abnormality of serum amino acid levels (HP:0003112) | 3.10676066 |
| 39 | Nausea (HP:0002018) | 3.10460512 |
| 40 | Rough bone trabeculation (HP:0100670) | 3.07818909 |
| 41 | Sparse eyelashes (HP:0000653) | 3.02549403 |
| 42 | Respiratory failure (HP:0002878) | 3.01486395 |
| 43 | Increased muscle lipid content (HP:0009058) | 3.00996316 |
| 44 | Amniotic constriction ring (HP:0009775) | 2.97989022 |
| 45 | Abnormality of placental membranes (HP:0011409) | 2.97989022 |
| 46 | Increased intramyocellular lipid droplets (HP:0012240) | 2.94256236 |
| 47 | Xanthomatosis (HP:0000991) | 2.92025170 |
| 48 | CNS demyelination (HP:0007305) | 2.91886081 |
| 49 | Progressive muscle weakness (HP:0003323) | 2.89768385 |
| 50 | Prolonged partial thromboplastin time (HP:0003645) | 2.89005087 |
| 51 | Generalized aminoaciduria (HP:0002909) | 2.87547936 |
| 52 | Reduced antithrombin III activity (HP:0001976) | 2.85130169 |
| 53 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.85016983 |
| 54 | Hypolipoproteinemia (HP:0010981) | 2.82879524 |
| 55 | Exercise intolerance (HP:0003546) | 2.82489879 |
| 56 | Renal Fanconi syndrome (HP:0001994) | 2.82444325 |
| 57 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.79787438 |
| 58 | Glycosuria (HP:0003076) | 2.76202010 |
| 59 | Abnormality of urine glucose concentration (HP:0011016) | 2.76202010 |
| 60 | Abnormality of methionine metabolism (HP:0010901) | 2.71897929 |
| 61 | Proximal tubulopathy (HP:0000114) | 2.70451069 |
| 62 | Ketosis (HP:0001946) | 2.70104958 |
| 63 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.66537728 |
| 64 | Long foot (HP:0001833) | 2.63399361 |
| 65 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.62966534 |
| 66 | Multiple enchondromatosis (HP:0005701) | 2.61643986 |
| 67 | Abnormality of the preputium (HP:0100587) | 2.61534600 |
| 68 | Chromsome breakage (HP:0040012) | 2.60049496 |
| 69 | Neoplasm of the adrenal gland (HP:0100631) | 2.56070553 |
| 70 | Birth length less than 3rd percentile (HP:0003561) | 2.56002150 |
| 71 | Deep venous thrombosis (HP:0002625) | 2.54860878 |
| 72 | Abnormal protein glycosylation (HP:0012346) | 2.53457448 |
| 73 | Abnormal glycosylation (HP:0012345) | 2.53457448 |
| 74 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.53457448 |
| 75 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.53457448 |
| 76 | Vomiting (HP:0002013) | 2.51743300 |
| 77 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.51268838 |
| 78 | Hyperlipoproteinemia (HP:0010980) | 2.51108484 |
| 79 | Rhabdomyolysis (HP:0003201) | 2.48045076 |
| 80 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.46587340 |
| 81 | Premature ovarian failure (HP:0008209) | 2.45707339 |
| 82 | Metabolic acidosis (HP:0001942) | 2.45370012 |
| 83 | Cerebral hypomyelination (HP:0006808) | 2.44422002 |
| 84 | Abnormal trabecular bone morphology (HP:0100671) | 2.38786432 |
| 85 | Methylmalonic aciduria (HP:0012120) | 2.37473392 |
| 86 | Pancytopenia (HP:0001876) | 2.35000765 |
| 87 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.33205144 |
| 88 | Abnormality of alanine metabolism (HP:0010916) | 2.33205144 |
| 89 | Hyperalaninemia (HP:0003348) | 2.33205144 |
| 90 | Breast hypoplasia (HP:0003187) | 2.32659914 |
| 91 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.30860123 |
| 92 | Trismus (HP:0000211) | 2.29896878 |
| 93 | Macrocytic anemia (HP:0001972) | 2.27768052 |
| 94 | Ketoacidosis (HP:0001993) | 2.26420758 |
| 95 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.25542758 |
| 96 | Delayed CNS myelination (HP:0002188) | 2.25348354 |
| 97 | Oral leukoplakia (HP:0002745) | 2.24201008 |
| 98 | Testicular atrophy (HP:0000029) | 2.24113787 |
| 99 | Leukodystrophy (HP:0002415) | 2.21844718 |
| 100 | Abnormal gallbladder physiology (HP:0012438) | 2.20957101 |
| 101 | Cholecystitis (HP:0001082) | 2.20957101 |
| 102 | Palpitations (HP:0001962) | 2.20444921 |
| 103 | Meckel diverticulum (HP:0002245) | 2.19505288 |
| 104 | Hypoalphalipoproteinemia (HP:0003233) | 2.17647875 |
| 105 | Respiratory difficulties (HP:0002880) | 2.15841131 |
| 106 | Microvesicular hepatic steatosis (HP:0001414) | 2.15107771 |
| 107 | Exertional dyspnea (HP:0002875) | 2.14735435 |
| 108 | Hyperphosphaturia (HP:0003109) | 2.13687697 |
| 109 | Opisthotonus (HP:0002179) | 2.13151608 |
| 110 | Ragged-red muscle fibers (HP:0003200) | 2.12387393 |
| 111 | Abnormality of nucleobase metabolism (HP:0010932) | 2.11829508 |
| 112 | Fat malabsorption (HP:0002630) | 2.11434464 |
| 113 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.11412600 |
| 114 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.10076512 |
| 115 | Abnormality of the ileum (HP:0001549) | 2.09985724 |
| 116 | Megaloblastic anemia (HP:0001889) | 2.09910512 |
| 117 | Reticulocytopenia (HP:0001896) | 2.08695158 |
| 118 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.06204982 |
| 119 | Abnormal number of erythroid precursors (HP:0012131) | 2.05212920 |
| 120 | Optic disc pallor (HP:0000543) | 2.04864189 |
| 121 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.04759853 |
| 122 | Myoglobinuria (HP:0002913) | 2.02413411 |
| 123 | Hyperbilirubinemia (HP:0002904) | 2.01926032 |
| 124 | Carpal bone hypoplasia (HP:0001498) | 2.00119526 |
| 125 | X-linked dominant inheritance (HP:0001423) | 1.98299354 |
| 126 | Hypokinesia (HP:0002375) | 1.96713888 |
| 127 | Brushfield spots (HP:0001088) | 1.96143790 |
| 128 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.96067945 |
| 129 | Gliosis (HP:0002171) | 1.95795778 |
| 130 | Diastasis recti (HP:0001540) | 1.92305217 |
| 131 | Emotional lability (HP:0000712) | 1.92233414 |
| 132 | Secondary amenorrhea (HP:0000869) | 1.90951171 |
| 133 | Progressive external ophthalmoplegia (HP:0000590) | 1.90364775 |
| 134 | Postnatal microcephaly (HP:0005484) | 1.88346593 |
| 135 | Death in infancy (HP:0001522) | 1.84596529 |
| 136 | Horseshoe kidney (HP:0000085) | 1.84314186 |
| 137 | Abnormality of renal resorption (HP:0011038) | 1.80527675 |
| 138 | Ureteral duplication (HP:0000073) | 1.77436834 |
| 139 | Posterior subcapsular cataract (HP:0007787) | 1.75624714 |
| 140 | Myelodysplasia (HP:0002863) | 1.75062993 |
| 141 | Abnormality of the umbilical cord (HP:0010881) | 1.74332362 |
| 142 | Squamous cell carcinoma (HP:0002860) | 1.73861575 |
| 143 | Abnormality of chromosome stability (HP:0003220) | 1.73564337 |
| 144 | Microretrognathia (HP:0000308) | 1.71172789 |
| 145 | Nemaline bodies (HP:0003798) | 1.70559930 |
| 146 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.70536663 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK16 | 5.06099132 |
| 2 | BUB1 | 4.24399555 |
| 3 | BCKDK | 4.11917574 |
| 4 | NME2 | 4.11621415 |
| 5 | EIF2AK1 | 4.11543320 |
| 6 | VRK2 | 3.47254198 |
| 7 | WEE1 | 3.46361143 |
| 8 | EIF2AK3 | 2.27363755 |
| 9 | PBK | 2.13170771 |
| 10 | SRPK1 | 2.07763590 |
| 11 | TSSK6 | 2.01174620 |
| 12 | NME1 | 1.97583142 |
| 13 | PDK3 | 1.89760189 |
| 14 | PDK4 | 1.89760189 |
| 15 | BRSK2 | 1.85994750 |
| 16 | PLK4 | 1.82195883 |
| 17 | NEK1 | 1.76750430 |
| 18 | TLK1 | 1.75833872 |
| 19 | TESK2 | 1.73414553 |
| 20 | MYLK | 1.67230113 |
| 21 | STK38L | 1.66398121 |
| 22 | PDK2 | 1.63400445 |
| 23 | KDR | 1.59049568 |
| 24 | IRAK3 | 1.51901134 |
| 25 | NEK9 | 1.50186059 |
| 26 | VRK1 | 1.48063098 |
| 27 | TRIM28 | 1.45795221 |
| 28 | SCYL2 | 1.38229023 |
| 29 | TTK | 1.36434565 |
| 30 | MKNK2 | 1.31194770 |
| 31 | ZAK | 1.31125568 |
| 32 | PIM2 | 1.30979623 |
| 33 | EPHA2 | 1.29999460 |
| 34 | MAP3K11 | 1.27567234 |
| 35 | PLK1 | 1.26344567 |
| 36 | ABL2 | 1.24835444 |
| 37 | OBSCN | 1.17797481 |
| 38 | BRAF | 1.14054295 |
| 39 | TESK1 | 1.13720589 |
| 40 | MAP3K3 | 1.13185336 |
| 41 | AURKA | 1.09562462 |
| 42 | ARAF | 1.08752086 |
| 43 | PRKG2 | 1.08389569 |
| 44 | STK10 | 1.06699247 |
| 45 | PLK3 | 1.01364290 |
| 46 | CDC7 | 1.01269918 |
| 47 | AURKB | 0.97739489 |
| 48 | MST4 | 0.95972688 |
| 49 | MKNK1 | 0.94188029 |
| 50 | LIMK1 | 0.93827069 |
| 51 | ACVR1B | 0.93593539 |
| 52 | BMPR1B | 0.89706937 |
| 53 | AKT3 | 0.86977778 |
| 54 | EIF2AK2 | 0.85280126 |
| 55 | BRSK1 | 0.82472004 |
| 56 | PIK3CG | 0.77061367 |
| 57 | NUAK1 | 0.75287755 |
| 58 | CSNK2A1 | 0.72576606 |
| 59 | CAMK2G | 0.70569020 |
| 60 | DYRK3 | 0.68179209 |
| 61 | DAPK3 | 0.66826283 |
| 62 | RPS6KA4 | 0.64244716 |
| 63 | CSNK2A2 | 0.63786736 |
| 64 | CDK9 | 0.63784436 |
| 65 | MAP3K12 | 0.62247453 |
| 66 | CDK7 | 0.60434387 |
| 67 | MAP2K3 | 0.59823838 |
| 68 | CDK8 | 0.59817515 |
| 69 | PAK4 | 0.59616550 |
| 70 | ERBB4 | 0.58623202 |
| 71 | CCNB1 | 0.58535191 |
| 72 | NEK2 | 0.58319535 |
| 73 | MAP3K8 | 0.58310017 |
| 74 | STK24 | 0.58092338 |
| 75 | ALK | 0.54802610 |
| 76 | PRKCI | 0.54544872 |
| 77 | RAF1 | 0.52998849 |
| 78 | ERBB3 | 0.52806379 |
| 79 | DYRK2 | 0.51520204 |
| 80 | CHEK2 | 0.49172186 |
| 81 | STK4 | 0.46820171 |
| 82 | MAPKAPK3 | 0.46142619 |
| 83 | AKT2 | 0.45254114 |
| 84 | CSNK1G3 | 0.45231456 |
| 85 | MAP3K5 | 0.44992819 |
| 86 | PINK1 | 0.44560835 |
| 87 | FLT3 | 0.44184730 |
| 88 | MAP3K9 | 0.43959014 |
| 89 | SMG1 | 0.43532398 |
| 90 | PIM1 | 0.42804208 |
| 91 | ATM | 0.41733520 |
| 92 | ILK | 0.41407805 |
| 93 | CAMK2D | 0.41290577 |
| 94 | TAOK2 | 0.40326540 |
| 95 | PLK2 | 0.40245049 |
| 96 | CAMK2B | 0.38110100 |
| 97 | MOS | 0.37949106 |
| 98 | CSNK1G1 | 0.37867937 |
| 99 | PAK1 | 0.37258132 |
| 100 | CLK1 | 0.36984707 |
| 101 | MST1R | 0.36613789 |
| 102 | LRRK2 | 0.34990890 |
| 103 | STK39 | 0.34441379 |
| 104 | RPS6KB2 | 0.33671621 |
| 105 | ATR | 0.33544828 |
| 106 | CDK4 | 0.33468199 |
| 107 | IRAK1 | 0.33465819 |
| 108 | ERN1 | 0.33162258 |
| 109 | CSNK1A1L | 0.32433198 |
| 110 | NEK6 | 0.32229335 |
| 111 | GRK6 | 0.32166793 |
| 112 | SIK3 | 0.29531144 |
| 113 | BMPR2 | 0.29223743 |
| 114 | LATS2 | 0.29069841 |
| 115 | MUSK | 0.28967153 |
| 116 | CSNK1E | 0.28407526 |
| 117 | RPS6KA5 | 0.27861291 |
| 118 | IRAK4 | 0.26853609 |
| 119 | MAPK4 | 0.26782613 |
| 120 | CDK1 | 0.26295483 |
| 121 | GRK7 | 0.25755885 |
| 122 | MAPK11 | 0.25318755 |
| 123 | MAPKAPK5 | 0.25129323 |
| 124 | STK3 | 0.23983946 |
| 125 | BCR | 0.23505030 |
| 126 | WNK3 | 0.20389946 |
| 127 | PIK3CA | 0.20380951 |
| 128 | CHEK1 | 0.19253208 |
| 129 | MET | 0.16805747 |
| 130 | DAPK1 | 0.16599647 |
| 131 | MARK3 | 0.16168053 |
| 132 | TGFBR1 | 0.16101791 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.43579888 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.70495715 |
| 3 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.63785990 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 2.59329242 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 2.41932315 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.35897903 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.15939782 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.14941767 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.12911728 |
| 10 | RNA polymerase_Homo sapiens_hsa03020 | 2.12010020 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.11826461 |
| 12 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.08375868 |
| 13 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.08256777 |
| 14 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.98803581 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.91815509 |
| 16 | DNA replication_Homo sapiens_hsa03030 | 1.85766921 |
| 17 | Carbon metabolism_Homo sapiens_hsa01200 | 1.79793855 |
| 18 | Huntingtons disease_Homo sapiens_hsa05016 | 1.78409983 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.73437552 |
| 20 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.70152878 |
| 21 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.68182323 |
| 22 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.67440509 |
| 23 | Peroxisome_Homo sapiens_hsa04146 | 1.61507831 |
| 24 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.61443654 |
| 25 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.60228426 |
| 26 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.60081385 |
| 27 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.59291885 |
| 28 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.55994494 |
| 29 | Alzheimers disease_Homo sapiens_hsa05010 | 1.53525691 |
| 30 | Mismatch repair_Homo sapiens_hsa03430 | 1.53244723 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.50834342 |
| 32 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.49854658 |
| 33 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.46056924 |
| 34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.45006911 |
| 35 | Protein export_Homo sapiens_hsa03060 | 1.43002576 |
| 36 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.41521312 |
| 37 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.41497443 |
| 38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.40353468 |
| 39 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.39508795 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.36501974 |
| 41 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.35434594 |
| 42 | Sulfur relay system_Homo sapiens_hsa04122 | 1.33779469 |
| 43 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.32080074 |
| 44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.32031475 |
| 45 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.31478966 |
| 46 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.31175861 |
| 47 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.29538592 |
| 48 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.24220715 |
| 49 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.23683045 |
| 50 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.22179751 |
| 51 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.19927335 |
| 52 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.18173107 |
| 53 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.16366409 |
| 54 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.13516491 |
| 55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.11813606 |
| 56 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.11079632 |
| 57 | RNA transport_Homo sapiens_hsa03013 | 1.10234848 |
| 58 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.07654494 |
| 59 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.06376005 |
| 60 | Spliceosome_Homo sapiens_hsa03040 | 1.06057257 |
| 61 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.04616162 |
| 62 | Homologous recombination_Homo sapiens_hsa03440 | 1.02522194 |
| 63 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.01112537 |
| 64 | Histidine metabolism_Homo sapiens_hsa00340 | 0.96932396 |
| 65 | Retinol metabolism_Homo sapiens_hsa00830 | 0.91357165 |
| 66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.88414704 |
| 67 | Base excision repair_Homo sapiens_hsa03410 | 0.88200954 |
| 68 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.88102151 |
| 69 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.88045986 |
| 70 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.87936124 |
| 71 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.83882174 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81754730 |
| 73 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.79991037 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.77767918 |
| 75 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.77004395 |
| 76 | Purine metabolism_Homo sapiens_hsa00230 | 0.74617274 |
| 77 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.73309181 |
| 78 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.72383862 |
| 79 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.69806053 |
| 80 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.67699973 |
| 81 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.65353986 |
| 82 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.64242150 |
| 83 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.63876269 |
| 84 | Basal transcription factors_Homo sapiens_hsa03022 | 0.63221055 |
| 85 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.60002447 |
| 86 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.59697856 |
| 87 | RNA degradation_Homo sapiens_hsa03018 | 0.58585924 |
| 88 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.57009285 |
| 89 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.53789101 |
| 90 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52755716 |
| 91 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.52078723 |
| 92 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.46771594 |
| 93 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.45184316 |
| 94 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.44788186 |
| 95 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.44561744 |
| 96 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.43747109 |
| 97 | Cell cycle_Homo sapiens_hsa04110 | 0.43413892 |
| 98 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.40093334 |
| 99 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.39814347 |
| 100 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.39375868 |
| 101 | Legionellosis_Homo sapiens_hsa05134 | 0.38508859 |
| 102 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.37730632 |
| 103 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.34222893 |
| 104 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.31731442 |
| 105 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.31253400 |
| 106 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.29972870 |
| 107 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.25907113 |
| 108 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.24451663 |
| 109 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.24354554 |
| 110 | Mineral absorption_Homo sapiens_hsa04978 | 0.22541651 |
| 111 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.22094840 |
| 112 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.19445732 |
| 113 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.18638005 |
| 114 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.18348280 |
| 115 | Shigellosis_Homo sapiens_hsa05131 | 0.17246547 |
| 116 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.14208215 |
| 117 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.13196497 |
| 118 | Apoptosis_Homo sapiens_hsa04210 | 0.10748139 |
| 119 | Circadian rhythm_Homo sapiens_hsa04710 | 0.07505020 |
| 120 | HTLV-I infection_Homo sapiens_hsa05166 | 0.06464886 |

